glp-1 drugs breastfeeding meds like Ozempic® and Wegovy® are everywhere — but what if you're breastfeeding? 🤱 Early studies show minimal transfer into breast milk, yet we don't have enough data to call them Ep. 84 - GLP-1 Medications
Description
[46] Preclinical studies suggest semaglutide counteracts these processes by activating the AMPK and SIRT1 pathways, which are fundamental for cellular autophagy and mitophagy

GoF receptors are often characterised by a greater propensity for G protein versus -arrestin recruitment and signalling, slower rate of receptor internalisation and rapid recycling back to the plasma membrane, with these characteristics being independent of their surface expression levels (Liu et al., 2022)

Future research directions include direct comparative trials between various GLP-1 RAs and multi-agonists in MASLD populations to identify optimal therapeutic choices for specific patient subgroups

[DOI] [PMC free article] [PubMed] [Google Scholar] 15.Athauda D, et al
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion

Similarly, oxyntomodulin, a natural peptide hormone secreted by intestinal L-cells following a meal, functions as a dual GLP-1R/GCGR agonist